Two new treatments for Alzheimer’s – lecanemab and donanemab – have been hailed as breakthroughs. In reality, they will have little effect.
Don’t buy the hype on new “breakthrough” Alzheimer’s treatments
Posted in biotech/medical, neuroscience
Posted in biotech/medical, neuroscience
Two new treatments for Alzheimer’s – lecanemab and donanemab – have been hailed as breakthroughs. In reality, they will have little effect.